197 related articles for article (PubMed ID: 10854106)
21. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
Lu C; Lin L; Tan H; Wu H; Sherman SL; Gao F; Jin P; Chen D
Hum Mol Genet; 2012 Dec; 21(23):5039-47. PubMed ID: 22914733
[TBL] [Abstract][Full Text] [Related]
22. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
[TBL] [Abstract][Full Text] [Related]
23. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.
Ennis S; Ward D; Murray A
Eur J Hum Genet; 2006 Feb; 14(2):253-5. PubMed ID: 16251893
[TBL] [Abstract][Full Text] [Related]
24. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.
Hundscheid RD; Smits AP; Thomas CM; Kiemeney LA; Braat DD
Am J Med Genet A; 2003 Feb; 117A(1):6-9. PubMed ID: 12548733
[TBL] [Abstract][Full Text] [Related]
25. Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation.
Kallinen J; Heinonen S; Mannermaa A; Ryynänen M
Clin Genet; 2000 Aug; 58(2):111-5. PubMed ID: 11005143
[TBL] [Abstract][Full Text] [Related]
26. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
Leehey MA; Berry-Kravis E; Goetz CG; Zhang L; Hall DA; Li L; Rice CD; Lara R; Cogswell J; Reynolds A; Gane L; Jacquemont S; Tassone F; Grigsby J; Hagerman RJ; Hagerman PJ
Neurology; 2008 Apr; 70(16 Pt 2):1397-402. PubMed ID: 18057320
[TBL] [Abstract][Full Text] [Related]
27. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
[TBL] [Abstract][Full Text] [Related]
28. Premature ovarian failure and FMR1 gene mutations: an update.
Conway GS
Ann Endocrinol (Paris); 2010 May; 71(3):215-7. PubMed ID: 20398889
[TBL] [Abstract][Full Text] [Related]
29. Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion.
Loesch DZ; Bui MQ; Hammersley E; Schneider A; Storey E; Stimpson P; Burgess T; Francis D; Slater H; Tassone F; Hagerman RJ; Hessl D
Clin Genet; 2015 Feb; 87(2):173-8. PubMed ID: 24428240
[TBL] [Abstract][Full Text] [Related]
30. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks.
Steyaert J; Legius E; Borghgraef M; Fryns JP
Am J Med Genet A; 2003 Jan; 116A(1):44-51. PubMed ID: 12476450
[TBL] [Abstract][Full Text] [Related]
31. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
[TBL] [Abstract][Full Text] [Related]
32. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
[TBL] [Abstract][Full Text] [Related]
33. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency.
Rosario R; Stewart HL; Choudhury NR; Michlewski G; Charlet-Berguerand N; Anderson RA
FASEB J; 2022 Nov; 36(11):e22612. PubMed ID: 36250920
[TBL] [Abstract][Full Text] [Related]
35. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
[TBL] [Abstract][Full Text] [Related]
36. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
Pandey UB; Phadke S; Mittal B
Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
[TBL] [Abstract][Full Text] [Related]
37. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction.
Syrrou M; Georgiou I; Patsalis PC; Bouba I; Adonakis G; Pagoulatos GN
Am J Med Genet; 1999 May; 84(3):306-8. PubMed ID: 10331614
[TBL] [Abstract][Full Text] [Related]
38. Expression of the FMR1 gene.
Tassone F; Hagerman PJ
Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
[TBL] [Abstract][Full Text] [Related]
39. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.
Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG
Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683
[TBL] [Abstract][Full Text] [Related]
40. Study of telomere length in men who carry a fragile X premutation or full mutation allele.
Albizua I; Chopra P; Allen EG; He W; Amin AS; Sherman SL
Hum Genet; 2020 Dec; 139(12):1531-1539. PubMed ID: 32533363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
